BioScale Raises $18.8M; Targets $38.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said in a regulatory document that it has raised $18.8 million of a targeted $38.3 million financing round.

The Lexington, Mass.-based firm disclosed the raise in a document filed on Monday with the US Securities and Exchange Commission, saying the securities offered were in the form of equity. It did not disclose the names of the investors but said 69 investors have invested in the offering. It did not say how proceeds from the raise would be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.